Personalized medicine products that bring the most recent advances in medical genetics, nutrigenomics, sports, reproductive genetics and pharmacogenomics closer to physicians and patients
Identification, in-silico validation and optimization platform for biomarkers with prognostic capability in cancer. Sinaptec 2017 award winner as an innovative project, presented in Silicon Valley.
Platform for inferring genomic and epigenomic mechanisms involved in tumour progression. Based in biostatistics, bioinformatics and machine learning techniques.